Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Stockholders Equity Over TimeContracting
Percentile Rank14
3Y CAGR-36.7%
5Y CAGR-23.6%
Year-over-Year Change
Net worth of the company (assets minus liabilities)
3Y CAGR
-36.7%/yr
Annual compound
5Y CAGR
-23.6%/yr
Recent deceleration
Percentile
P14
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
4 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $30.15M | -64.6% |
| 2023 | $85.08M | -15.4% |
| 2022 | $100.59M | -15.2% |
| 2021 | $118.59M | -31.2% |
| 2020 | $172.26M | +49.2% |
| 2019 | $115.48M | +61.7% |
| 2018 | $71.42M | +452.2% |
| 2017 | $-20.28M | - |